Four-Dollar Generics — Increased Accessibility, Impaired Quality Assurance
The affordability of prescription medications is one of the most pressing public health issues in the United States. Many patients take less than their prescribed doses to make medications last longer or do not fill prescriptions at all because of cost. 1 Both patients without insurance coverage for...
Gespeichert in:
| Veröffentlicht in: | The New England journal of medicine 2010-11, Vol.363 (20), p.1885-1887 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1887 |
|---|---|
| container_issue | 20 |
| container_start_page | 1885 |
| container_title | The New England journal of medicine |
| container_volume | 363 |
| creator | Choudhry, Niteesh K Shrank, William H |
| description | The affordability of prescription medications is one of the most pressing public health issues in the United States. Many patients take less than their prescribed doses to make medications last longer or do not fill prescriptions at all because of cost.
1
Both patients without insurance coverage for drugs and those with such coverage underuse medications because of cost
2
— and this problem has grown as employers have cut back on drug benefits. The failure to provide essential medications for chronic diseases may have massive adverse consequences for public health and the overall costs of health care. As we prepare to . . . |
| doi_str_mv | 10.1056/NEJMp1006189 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_764493599</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2186944921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-3deef3c44b855e4e8aac849f0b70e0eab251d7793efcd1b7c7da0a766afb51f73</originalsourceid><addsrcrecordid>eNptkM1KAzEUhYMoWqs71zKI4KajSfM3WZba1kpVBF0PmcwNTJk_k86iOx_CJ_RJTGkVEe_mwuHjcM5B6Izga4K5uHmc3D-0BGNBErWHeoRTGjOGxT7qYTxMYiYVPULH3i9xOMLUIToaEiwklaqHFtOmc_FtU5baRTOowRXGR5_vH9G8Ng60hzwaGQPeF1lRFqv1IJpXrS5c0J87vVGikfed07WBE3RgdenhdPf76HU6eRnfxYun2Xw8WsSGJmoV0xzAUsNYlnAODBKtTcKUxZnEgEFnQ05yGWKDNTnJpJG5xloKoW3GiZW0j662vq1r3jrwq7QqvIHQoYam86kUjCnKlQrkxR9yGfrWIVyAKE8IFRu7wRYyrvHegU1bV1TarVOC083G6e-NA36-8-yyCvIf-HvUAFxugaryaQ3L6n-fL-Avgq0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>763581367</pqid></control><display><type>article</type><title>Four-Dollar Generics — Increased Accessibility, Impaired Quality Assurance</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Choudhry, Niteesh K ; Shrank, William H</creator><creatorcontrib>Choudhry, Niteesh K ; Shrank, William H</creatorcontrib><description>The affordability of prescription medications is one of the most pressing public health issues in the United States. Many patients take less than their prescribed doses to make medications last longer or do not fill prescriptions at all because of cost.
1
Both patients without insurance coverage for drugs and those with such coverage underuse medications because of cost
2
— and this problem has grown as employers have cut back on drug benefits. The failure to provide essential medications for chronic diseases may have massive adverse consequences for public health and the overall costs of health care. As we prepare to . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMp1006189</identifier><identifier>PMID: 21067379</identifier><identifier>CODEN: NEJMAG</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Cardiovascular disease ; Chronic illnesses ; Clinical Pharmacy Information Systems - organization & administration ; Costs ; Drug Costs ; Drugs, Generic - economics ; Generic drugs ; Health Services Accessibility - economics ; Humans ; Insurance Benefits ; Insurance coverage ; Insurance, Pharmaceutical Services ; Patient Compliance ; Pharmaceutical Services - economics ; Pharmaceutical Services - organization & administration ; Pharmacy ; Pharmacy benefit management ; Prescription drugs ; Public health ; Quality Assurance, Health Care ; Reimbursement Mechanisms - organization & administration ; United States</subject><ispartof>The New England journal of medicine, 2010-11, Vol.363 (20), p.1885-1887</ispartof><rights>Copyright © 2010 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-3deef3c44b855e4e8aac849f0b70e0eab251d7793efcd1b7c7da0a766afb51f73</citedby><cites>FETCH-LOGICAL-c389t-3deef3c44b855e4e8aac849f0b70e0eab251d7793efcd1b7c7da0a766afb51f73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMp1006189$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/763581367?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,2758,2759,26102,27923,27924,52381,54063,64384,64386,64388,72340</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21067379$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Choudhry, Niteesh K</creatorcontrib><creatorcontrib>Shrank, William H</creatorcontrib><title>Four-Dollar Generics — Increased Accessibility, Impaired Quality Assurance</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>The affordability of prescription medications is one of the most pressing public health issues in the United States. Many patients take less than their prescribed doses to make medications last longer or do not fill prescriptions at all because of cost.
1
Both patients without insurance coverage for drugs and those with such coverage underuse medications because of cost
2
— and this problem has grown as employers have cut back on drug benefits. The failure to provide essential medications for chronic diseases may have massive adverse consequences for public health and the overall costs of health care. As we prepare to . . .</description><subject>Cardiovascular disease</subject><subject>Chronic illnesses</subject><subject>Clinical Pharmacy Information Systems - organization & administration</subject><subject>Costs</subject><subject>Drug Costs</subject><subject>Drugs, Generic - economics</subject><subject>Generic drugs</subject><subject>Health Services Accessibility - economics</subject><subject>Humans</subject><subject>Insurance Benefits</subject><subject>Insurance coverage</subject><subject>Insurance, Pharmaceutical Services</subject><subject>Patient Compliance</subject><subject>Pharmaceutical Services - economics</subject><subject>Pharmaceutical Services - organization & administration</subject><subject>Pharmacy</subject><subject>Pharmacy benefit management</subject><subject>Prescription drugs</subject><subject>Public health</subject><subject>Quality Assurance, Health Care</subject><subject>Reimbursement Mechanisms - organization & administration</subject><subject>United States</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkM1KAzEUhYMoWqs71zKI4KajSfM3WZba1kpVBF0PmcwNTJk_k86iOx_CJ_RJTGkVEe_mwuHjcM5B6Izga4K5uHmc3D-0BGNBErWHeoRTGjOGxT7qYTxMYiYVPULH3i9xOMLUIToaEiwklaqHFtOmc_FtU5baRTOowRXGR5_vH9G8Ng60hzwaGQPeF1lRFqv1IJpXrS5c0J87vVGikfed07WBE3RgdenhdPf76HU6eRnfxYun2Xw8WsSGJmoV0xzAUsNYlnAODBKtTcKUxZnEgEFnQ05yGWKDNTnJpJG5xloKoW3GiZW0j662vq1r3jrwq7QqvIHQoYam86kUjCnKlQrkxR9yGfrWIVyAKE8IFRu7wRYyrvHegU1bV1TarVOC083G6e-NA36-8-yyCvIf-HvUAFxugaryaQ3L6n-fL-Avgq0</recordid><startdate>20101111</startdate><enddate>20101111</enddate><creator>Choudhry, Niteesh K</creator><creator>Shrank, William H</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20101111</creationdate><title>Four-Dollar Generics — Increased Accessibility, Impaired Quality Assurance</title><author>Choudhry, Niteesh K ; Shrank, William H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-3deef3c44b855e4e8aac849f0b70e0eab251d7793efcd1b7c7da0a766afb51f73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Cardiovascular disease</topic><topic>Chronic illnesses</topic><topic>Clinical Pharmacy Information Systems - organization & administration</topic><topic>Costs</topic><topic>Drug Costs</topic><topic>Drugs, Generic - economics</topic><topic>Generic drugs</topic><topic>Health Services Accessibility - economics</topic><topic>Humans</topic><topic>Insurance Benefits</topic><topic>Insurance coverage</topic><topic>Insurance, Pharmaceutical Services</topic><topic>Patient Compliance</topic><topic>Pharmaceutical Services - economics</topic><topic>Pharmaceutical Services - organization & administration</topic><topic>Pharmacy</topic><topic>Pharmacy benefit management</topic><topic>Prescription drugs</topic><topic>Public health</topic><topic>Quality Assurance, Health Care</topic><topic>Reimbursement Mechanisms - organization & administration</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Choudhry, Niteesh K</creatorcontrib><creatorcontrib>Shrank, William H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Choudhry, Niteesh K</au><au>Shrank, William H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Four-Dollar Generics — Increased Accessibility, Impaired Quality Assurance</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2010-11-11</date><risdate>2010</risdate><volume>363</volume><issue>20</issue><spage>1885</spage><epage>1887</epage><pages>1885-1887</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><coden>NEJMAG</coden><abstract>The affordability of prescription medications is one of the most pressing public health issues in the United States. Many patients take less than their prescribed doses to make medications last longer or do not fill prescriptions at all because of cost.
1
Both patients without insurance coverage for drugs and those with such coverage underuse medications because of cost
2
— and this problem has grown as employers have cut back on drug benefits. The failure to provide essential medications for chronic diseases may have massive adverse consequences for public health and the overall costs of health care. As we prepare to . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>21067379</pmid><doi>10.1056/NEJMp1006189</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-4793 |
| ispartof | The New England journal of medicine, 2010-11, Vol.363 (20), p.1885-1887 |
| issn | 0028-4793 1533-4406 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_764493599 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; New England Journal of Medicine |
| subjects | Cardiovascular disease Chronic illnesses Clinical Pharmacy Information Systems - organization & administration Costs Drug Costs Drugs, Generic - economics Generic drugs Health Services Accessibility - economics Humans Insurance Benefits Insurance coverage Insurance, Pharmaceutical Services Patient Compliance Pharmaceutical Services - economics Pharmaceutical Services - organization & administration Pharmacy Pharmacy benefit management Prescription drugs Public health Quality Assurance, Health Care Reimbursement Mechanisms - organization & administration United States |
| title | Four-Dollar Generics — Increased Accessibility, Impaired Quality Assurance |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T13%3A38%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Four-Dollar%20Generics%20%E2%80%94%20Increased%20Accessibility,%20Impaired%20Quality%20Assurance&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Choudhry,%20Niteesh%20K&rft.date=2010-11-11&rft.volume=363&rft.issue=20&rft.spage=1885&rft.epage=1887&rft.pages=1885-1887&rft.issn=0028-4793&rft.eissn=1533-4406&rft.coden=NEJMAG&rft_id=info:doi/10.1056/NEJMp1006189&rft_dat=%3Cproquest_cross%3E2186944921%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=763581367&rft_id=info:pmid/21067379&rfr_iscdi=true |